Page last updated: 2024-08-21

quinazolines and Alopecia Cicatrisata

quinazolines has been researched along with Alopecia Cicatrisata in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (33.33)	29.6817
2010's	12 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chai, M; Chu, J; Crooks, GM; de Barros, SC; Doan, NB; Fu, X; Herschman, H; Huang, J; Huang, W; Jiang, M; Jiao, J; Reue, K; Vergnes, L	1
Chu, CY; Hauschild, A; Lacouture, ME; O'Brien, D; Schadendorf, D; Stammberger, U; Uttenreuther-Fischer, M	1
Chen, PC; Chu, CY; Shih, YH	1
Bichsel, KJ; Forney, E; Gogia, N; Hammiller, B; Hansen, LA; Malouff, T; Pena, Z; Watson, P	1
Hong, W; Huang, Q; Liu, Y; Sun, X; Wu, J; Wu, W	1
Abdel-Rahman, O; Fouad, M	1
Aogi, K; Armour, A; Inoue, K; Iwata, H; Kuroi, K; Masuda, N; Nakayama, T; Nishimura, Y; Rai, Y; Sasaki, Y; Shimizu, S	1
Ena, L; Ena, P; Fadda, GM; Farris, A; Santeufemia, DA	1
Donovan, JC; Ghazarian, DM; Shaw, JC	1
Demierre, MF; Goldberg, LJ; Pongpudpunth, M	1
Carney, D; Forde, P; Murphy, C; O'Sullivan, C	1
Drillenburg, P; Hoekzema, R	1
Anadkat, MJ; Hepper, DM; Wu, P	1
Nakamura-Wakatsuki, T; Yamamoto, T	1
Fujii, N; Fujimoto, N; Kato, T; Nagao, T; Nakanishi, G; Tanaka, T; Toda, N	1
Burt, PA; Lee, LW	1
Graves, JE; Heffernan, MP; Jones, BF; Lind, AC	1
Costa, DB; Kobayashi, S; Schumer, ST	1

Reviews

4 review(s) available for quinazolines and Alopecia Cicatrisata

Article	Year
Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Expert review of anticancer therapy, 2013, Volume: 13, Issue:6 Topics: Administration, Oral; Afatinib; Alopecia; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; ErbB Receptors; Exanthema; Humans; Paronychia; Protein Kinase Inhibitors; Pruritus; Quinazolines; Receptor, ErbB-2	2013
Raltitrexed-based chemotherapy for advanced colorectal cancer. Clinics and research in hepatology and gastroenterology, 2014, Volume: 38, Issue:2 Topics: Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Chemical and Drug Induced Liver Injury; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Mucositis; Nausea; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Randomized Controlled Trials as Topic; Stomatitis; Thiophenes; Vomiting	2014
Risk of mucocutaneous toxicities in patients with solid tumors treated with lapatinib: a systematic review and meta-analysis. Current medical research and opinion, 2015, Volume: 31, Issue:5 Topics: Alopecia; Antineoplastic Agents; Hand-Foot Syndrome; Humans; Lapatinib; Neoplasms; Pruritus; Quinazolines; Randomized Controlled Trials as Topic; Risk	2015
Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors. Dermatology (Basel, Switzerland), 2012, Volume: 225, Issue:1 Topics: Aged; Alopecia; Antineoplastic Agents; Asian People; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Scalp Dermatoses	2012

Trials

1 trial(s) available for quinazolines and Alopecia Cicatrisata

Article	Year
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:6 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Diarrhea; Female; Hemoglobins; Humans; Japan; Lapatinib; Middle Aged; Neoplasm Metastasis; Paclitaxel; Quinazolines; Receptor, ErbB-2; Survival Rate	2015

Article

Year

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.

International journal of clinical oncology, 2015, Volume: 20, Issue:6

Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Diarrhea; Female; Hemoglobins; Humans; Japan; Lapatinib; Middle Aged; Neoplasm Metastasis; Paclitaxel; Quinazolines; Receptor, ErbB-2; Survival Rate

2015

Other Studies

13 other study(ies) available for quinazolines and Alopecia Cicatrisata

Article	Year
Stimulation of Hair Growth by Small Molecules that Activate Autophagy. Cell reports, 2019, 06-18, Volume: 27, Issue:12 Topics: Aging; Allyl Compounds; Alopecia; AMP-Activated Protein Kinases; Animals; Autophagy; Butyrates; Cell Division; Female; Hair; Hair Follicle; Ketoglutaric Acids; Male; Metformin; Mice; Mice, Inbred C57BL; Oligomycins; Quinazolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2019
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-10, Volume: 31, Issue:20 Topics: Aged; Alopecia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cicatrix; Female; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Quinazolines; Risk Assessment; Severity of Illness Index	2013
Role for the epidermal growth factor receptor in chemotherapy-induced alopecia. PloS one, 2013, Volume: 8, Issue:7 Topics: Alopecia; Animals; Antineoplastic Agents; Apoptosis; Cyclophosphamide; Disease Progression; Drug Tolerance; ErbB Receptors; Erlotinib Hydrochloride; Hair Follicle; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Mutation; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Tumor Suppressor Protein p53	2013
Tufted hair folliculitis in a woman treated with lapatinib for breast cancer. Clinical and experimental dermatology, 2008, Volume: 33, Issue:6 Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Folliculitis; Granuloma, Pyogenic; Humans; Lapatinib; Middle Aged; Quinazolines	2008
Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib. Archives of dermatology, 2008, Volume: 144, Issue:11 Topics: Aged; Alopecia; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cicatrix; Disease Progression; ErbB Receptors; Fatal Outcome; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Quinazolines; Risk Assessment	2008
A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib. Journal of cutaneous pathology, 2009, Volume: 36, Issue:12 Topics: Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Inflammation; Lung Neoplasms; Middle Aged; Quinazolines	2009
Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer. Irish journal of medical science, 2011, Volume: 180, Issue:1 Topics: Adenocarcinoma; Alopecia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines	2011
Folliculitis decalvans associated with erlotinib. Clinical and experimental dermatology, 2010, Volume: 35, Issue:8 Topics: Alopecia; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Folliculitis; Humans; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Staphylococcus aureus	2010
Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:5 Topics: Aged; Alopecia; Carcinoma, Non-Small-Cell Lung; Cicatrix; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Quinazolines	2011
Purpuric drug eruption and alopecia induced by erlotinib. Dermatology online journal, 2012, May-15, Volume: 18, Issue:5 Topics: Adenocarcinoma; Aged; Alopecia; Dermis; Drug Eruptions; Erlotinib Hydrochloride; Humans; Leg; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines	2012
Hair growth after gefitinib treatment. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:6 Topics: Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; ErbB Receptors; Gefitinib; Hair; Humans; Hypertrichosis; Lung Neoplasms; Male; Middle Aged; Quinazolines	2005
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2 Topics: Aged; Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Gefitinib; Humans; Inflammation; Lung Neoplasms; Quinazolines; Time Factors	2006
Erlotinib-associated alopecia in a lung cancer patient. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:12 Topics: Aged; Alopecia; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Risk Assessment	2007